BAKER-GLENN, CHARLES,BURDICK, DANIEL JON,CHAMBERS, MARK,CHEN, HUIFEN,ESTRADA, ANTHONY,SWEENEY, ZACHARY KEVIN,CHAN, BRYAN K.
申请号：
CA2812669
公开号：
CA2812669C
申请日:
2011.11.09
申请国别(地区):
CA
年份:
2018
代理人:
摘要：
Compounds of the formula (I), or pharmaceutically acceptable salts thereof, wherein X, R1, R2, R3, R4 and R5 are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of diseases associated with LRRK2 receptor, such as Parkinson's disease.
